Patient and caregiver perspectives on transitioning to oral prophylaxis in the emerging hereditary angioedema treatment landscape

Patient and caregiver perspectives on transitioning to oral prophylaxis in the emerging hereditary angioedema treatment landscape

Abstract This report describes the successful transition of two familial patients with HAE from injectable to oral prophylaxis without tapering prior therapy or employing a complex transition protocol.

Bibliographic Details
Main Authors: Daniel F. Soteres, Fellicia Grimes
Format: Article
Language:English
Published: Wiley 2021-11-01
Series:Clinical Case Reports
Subjects:
berotralstat
Haegarda
hereditary angioedema
shared decision‐making
switching
treatment burden
Online Access:https://doi.org/10.1002/ccr3.5086

Internet

https://doi.org/10.1002/ccr3.5086

Similar Items